| Bio |
Richard is an early-stage investor with a focus on Life Science. Corang Capital is based in London with offices in Australia and San Francisco.
Richard has a specialised knowledge of the US Market and the FDA approval process. He works with Health and Human Services through the Biomedical Advanced Research Development Agency, DRIVe (Division of Research, Innovation, and Ventures and DARPA-H.
|
